Home Clinical Topics Effectiveness of abaloparatide in patients with osteoporosis

Effectiveness of abaloparatide in patients with osteoporosis

Subcutaneous abaloparatide reduces the risk of new vertebral and nonvertebral fractures over 18 months in patients with osteoporosis, according to a study in JAMA. Read more

LEAVE A REPLY

Please enter your comment!
Please enter your name here